瘤微环境中的Neuromedin U - - 瘤进展中的可能作用
Patrycja Przygodzka1, Izabela Szulc-Kielbik1, Michal Kielbik1
1Institute of Medical Biology, Polish Academy of Sciences, 106 Lodowa Str., 93-232 Lodz, Poland.
Biochimica et biophysica acta. Reviews on cancer
|January 22, 2025
概括
神经胺U (NMU) 是一种在瘤微环境 (TME) 中发现的. 癌细胞分泌的NMU激活TME成分,促进瘤生长和进展,表明NMU是潜在的治疗标.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 免疫学 免疫学 免疫学
背景情况:
- 瘤微环境 (TME) 对癌症进展至关重要,也是关键的治疗点.
- 神经胺U (NMU) 是TME中发现的一种,在细胞通信中起作用.
- NMU受体存在于癌细胞和各种非恶性TME组件上.
研究的目的:
- 探索NMU在癌症进展中的作用.
- 讨论NMU对TME蜂组件的影响.
- 评估NMU及其受体作为潜在的癌症治疗方法.
主要方法:
- 对NMU及其癌症受体研究的文献综述.
- 对表达NMU及其受体的癌症组织和细胞类型的分析.
- 在TME中对NMU受体阳性细胞类型的临界选择.
主要成果:
- 癌细胞分泌的NMU激活了TME组件.
- 这种激活有助于形成支持瘤生长的微环境.
- 在各种恶性瘤TME中发现了NMU及其受体.
结论:
- NMU信号涉及到促进一种亲瘤的TME.
- NMU及其受体代表了癌症治疗的有前途的治疗标.
- 总结了调节国家大学活动的可用工具.
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Destabilization of Microtubules
2.7K
The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
2.7K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K


